Zobrazeno 1 - 10
of 60
pro vyhledávání: '"M. Menault"'
Autor:
C. Colin, P. Vergnon, A. M. Jullien, S. Excoffier, Y. Matillon, C. Trepo, J. P. Aymard, D. Bastit, M. L. Bidet, R. Breviere, F. Chenais, F. Hau, D. Houssay, A. Mercadier, P. Maisonneuve, M. Lambert, C. Waller, D. Boudart, C. Cotte, M. H. Elghouzzi, C. Janot, M. Daudet, M. Menault, M. Montcharmont, W. Smilovici, C. Fretz, R. Follana, M. Doillon, J. C. Petit, P. Herve, B. Loyer, B. Mattlinger
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 16:220-227
The current approach to screening for hepatitis C and non-A, non-B, non-C hepatitis in French blood transfusion centers involves a combination of a transaminase assay and tests for antibodies to hepatitis B core antigen (anti-HBc) and antibodies to h
Etude analytique des trousses de dépistage et de confirmation des anticorps anti-VHC Abbott et Ortho
Autor:
M.H. Elghouzzi, M. L. North, D. Boudart, P. Opolon, C. Janot, F. Mesnier, C. Cotte, M. Menault, C. Trepo, M. Maniez-Montreuil, J.M. Lemaire, P. Maisonneuve, B. Mattlinger, W. Smilovici, Anne-Marie Couroucé, L. Mouillot, A.M. Jullien
Publikováno v:
Revue Française de Transfusion et d'Hémobiologie. 35:171-182
Resume Le depistage systematique des anticorps anti-VHC est obligatoire sur chaque don de sang en France depuis le 1 er mars 1990. Quatre trousses de depistage des anticorps anti-VHC et quatre procedures de validation sont successivement proposees pa
Autor:
P. Moncharmont, C. Janot, D. Boudart, C. Cotte, A.M. Couroucé, M.H. Elghouzzi, A.M. Jullien, J.M. Lemaire, P. Maisonneuve, M. Maniez-Montreuil, B. Mattlinger, M. Menault, F. Mesnier, L. Mouillot, M.L. North, P. Opolon, W. Smilovici, C. Trepo
Publikováno v:
Revue Française de Transfusion et d'Hémobiologie. 35:205-210
Hepatitis C virus (HCV) discovery and introduction of anti-HCV antibodies screening in blood transfusion imply the necessity of a good blood donations and blood donors policy. Detection of a seropositivity during the screening must be completed with
Autor:
C. Trepo, P. Opolon, C. Janot, D. Boudart, C. Cotte, A.M. Courouce, M.H. Elghouzzi, A.M. Jullien, J.M. Lemaire, P. Maisonneuve, M. Maniez-Montreuil, B. Mattlinger, M. Menault, F. Mesnier, P. Moncharmont, L. Mouillot, M.L. North, W. Smilovici
Publikováno v:
Revue Française de Transfusion et d'Hémobiologie. 34:285-294
By now in France HBV seric markers (Ag HBs and Ac HBc) and transaminases level (ALT) screenings are compulsory by law in blood donors. People whose blood donation is discarded should be informed. A clinical, epidemiological and virological survey of
Publikováno v:
Revue Française de Transfusion et d'Hémobiologie. 33:355-358
Publikováno v:
Nephron. 63(4)
In order to appreciate the frequency of hepatitis B virus (HBV) infection in patients with glomerular diseases in France, a low endemic country, we reviewed the series of patients biopsied in the years 1983-1989 in 2 departments of nephrology differi
Publikováno v:
Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine. 33(5)
Publikováno v:
La Nouvelle presse medicale. 7(32)
Twelve patients on haemodialysis for 6 months to 3 years contracted AgHBs positive hepatitis, 9 being also Ag e positive. They continued to carry the same antigens. Histological surveillance was begun from the 6th month of the disease onwards, with 2
Publikováno v:
La Nouvelle presse medicale. 11(18)
A 45-year-old woman who had undergone bilateral nephrectomy and splenectomy and who had been under haemodialysis since 1966 developed non-A non-B cytolytic hepatitis in October, 1978. Her haematocrit and haemoglobin levels had been stable at 39% and
Publikováno v:
Annales de medecine interne. 126(6-7)